Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Clinical trial NCT00970268 · COMPLETED
Trial details
- NCT number
- NCT00970268
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-10-01
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.